XENETIC BIOSCIENCES, INC. (XBIO) Shareholders’ equity 2016–2025
XENETIC BIOSCIENCES, INC. (XBIO) shareholders’ equity at each fiscal year-end, per SEC filings.
$7.4MFY2025 · since FY2016: $16.2M → $7.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $7.4M | +23.1% |
| FY2024 | $6.0M | -38.7% |
| FY2023 | $9.8M | -28.2% |
| FY2022 | $13.6M | -25.8% |
| FY2021 | $18.4M | +50.6% |
| FY2020 | $12.2M | -29.0% |
| FY2019 | $17.2M | +73.6% |
| FY2018 | $9.9M | -30.7% |
| FY2017 | $14.3M | -11.6% |
| FY2016 | $16.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice